Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvesco in Refractory Steroid-responsive Asthma
NCT01171365Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Jan 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ciclesonide in eosinophilic asthma (EA), sponsored by University of Nottingham. Started Jan 2010; status: completed.
02
Drugs
ciclesonide
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on NCT01171365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171365.